225 related articles for article (PubMed ID: 15185351)
21. Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production.
Zimecki M; Miedzybrodzki R; Szymaniec S
Arch Immunol Ther Exp (Warsz); 1998; 46(6):361-5. PubMed ID: 9883315
[TBL] [Abstract][Full Text] [Related]
22. Bovine lactoferrin induces interleukin-11 production in a hepatitis mouse model and human intestinal myofibroblasts.
Kuhara T; Yamauchi K; Iwatsuki K
Eur J Nutr; 2012 Apr; 51(3):343-51. PubMed ID: 21688123
[TBL] [Abstract][Full Text] [Related]
23. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
[TBL] [Abstract][Full Text] [Related]
24. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.
Machnicki M; Zimecki M; Zagulski T
Int J Exp Pathol; 1993 Oct; 74(5):433-9. PubMed ID: 8217778
[TBL] [Abstract][Full Text] [Related]
25. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine.
Kuhara T; Yamauchi K; Tamura Y; Okamura H
J Interferon Cytokine Res; 2006 Jul; 26(7):489-99. PubMed ID: 16800788
[TBL] [Abstract][Full Text] [Related]
26. Oral bovine lactoferrin improves bone status of ovariectomized mice.
Blais A; Malet A; Mikogami T; Martin-Rouas C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1281-8. PubMed ID: 19336659
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of angiogenesis in vivo by interleukin 12.
Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
[TBL] [Abstract][Full Text] [Related]
28. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
29. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
Mader JS; Smyth D; Marshall J; Hoskin DW
Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional anti-angiogenic activity of the cyclic peroxide ANO-2 with antitumor activity.
Arakawa K; Endo Y; Kimura M; Yoshida T; Kitaoka T; Inakazu T; Nonami Y; Abe M; Masuyama A; Nojima M; Sasaki T
Int J Cancer; 2002 Jul; 100(2):220-7. PubMed ID: 12115573
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine.
Nishikawa T; Akiyama N; Kunimasa K; Oikawa T; Ishizuka M; Tsujimoto M; Natori S
Eur J Pharmacol; 2006 Jun; 539(3):151-7. PubMed ID: 16725138
[TBL] [Abstract][Full Text] [Related]
32. Effect of Bovine Lactoferrin Treatment Followed by Acute Stress on the IgA-Response in Small Intestine of BALB/c Mice.
Peña-Juárez MC; Campos-Rodríguez R; Godínez-Victoria M; Cruz-Hernández TR; Reyna-Garfias H; Barbosa-Cabrera RE; Drago-Serrano ME
Immunol Invest; 2016 Oct; 45(7):652-67. PubMed ID: 27611298
[TBL] [Abstract][Full Text] [Related]
33. Lactoferrin increases the output of neutrophil precursors and attenuates the spontaneous production of TNF-alpha and IL-6 by peripheral blood cells.
Zimecki M; Spiegel K; Właszczyk A; Kübler A; Kruzel ML
Arch Immunol Ther Exp (Warsz); 1999; 47(2):113-8. PubMed ID: 10202564
[TBL] [Abstract][Full Text] [Related]
34. Bovine Lactoferrin Suppresses Tumor Angiogenesis through NF-κB Pathway Inhibition by Binding to TRAF6.
Ayuningtyas NF; Chea C; Ando T; Saninggar KE; Tanimoto K; Inubushi T; Maishi N; Hida K; Shindoh M; Miyauchi M; Takata T
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678795
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice.
Iigo M; Kuhara T; Ushida Y; Sekine K; Moore MA; Tsuda H
Clin Exp Metastasis; 1999 Feb; 17(1):35-40. PubMed ID: 10390145
[TBL] [Abstract][Full Text] [Related]
36. Influences of orally administered lactoferrin on IFN-gamma and IL-10 production by intestinal intraepithelial lymphocytes and mesenteric lymph-node cells.
Takakura N; Wakabayashi H; Yamauchi K; Takase M
Biochem Cell Biol; 2006 Jun; 84(3):363-8. PubMed ID: 16936808
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis.
Hayashida K; Kaneko T; Takeuchi T; Shimizu H; Ando K; Harada E
J Vet Med Sci; 2004 Feb; 66(2):149-54. PubMed ID: 15031542
[TBL] [Abstract][Full Text] [Related]
38. Dietary lactoferrin does not prevent dextran sulfate sodium induced murine intestinal lymphocyte death.
Spagnuolo PA; Hoffman-Goetz L
Exp Biol Med (Maywood); 2008 Sep; 233(9):1099-108. PubMed ID: 18535168
[TBL] [Abstract][Full Text] [Related]
39. Effect of bovine lactoferrin on functions of activated feline peripheral blood mononuclear cells during chronic feline immunodeficiency virus infection.
Kobayashi S; Sato R; Aoki T; Omoe K; Inanami O; Hankanga C; Yamada Y; Tomizawa N; Yasuda J; Sasaki J
J Vet Med Sci; 2008 May; 70(5):429-35. PubMed ID: 18525162
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse.
Ushida Y; Sekine K; Kuhara T; Takasuka N; Iigo M; Tsuda H
Cancer Lett; 1998 Dec; 134(2):141-5. PubMed ID: 10025873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
